144 related articles for article (PubMed ID: 37434025)
1. Analysis of acute COVID-19 including chronic morbidity: protocol for the deep phenotyping National Pandemic Cohort Network in Germany (NAPKON-HAP).
Steinbeis F; Thibeault C; Steinbrecher S; Ahlgrimm Y; Haack IA; August D; Balzuweit B; Bellinghausen C; Berger S; Chaplinskaya-Sobol I; Cornely O; Doeblin P; Endres M; Fink C; Finke C; Frank S; Hanß S; Hartung T; Hellmuth JC; Herold S; Heuschmann P; Heyckendorf J; Heyder R; Hippenstiel S; Hoffmann W; Kelle SU; Knape P; Koehler P; Kretzler L; Leistner DM; Lienau J; Lorbeer R; Lorenz-Depiereux B; Lüttke CD; Mai K; Merle U; Meyer-Arndt LA; Miljukov O; Muenchhoff M; Müller-Plathe M; Neuhann J; Neuhauser H; Nieters A; Otte C; Pape D; Pinto RM; Pley C; Pudszuhn A; Reuken P; Rieg S; Ritter P; Rohde G; Rönnefarth M; Ruzicka M; Schaller J; Schmidt A; Schmidt S; Schwachmeyer V; Schwanitz G; Seeger W; Stahl D; Stobäus N; Stubbe HC; Suttorp N; Temmesfeld B; Thun S; Triller P; Trinkmann F; Vadasz I; Valentin H; Vehreschild M; von Kalle C; von Lilienfeld-Toal M; Weber J; Welte T; Wildberg C; Wizimirski R; Zvork S; Sander LE; Vehreschild J; Zoller T; Kurth F; Witzenrath M
Infection; 2024 Feb; 52(1):93-104. PubMed ID: 37434025
[TBL] [Abstract][Full Text] [Related]
2. Studying the pathophysiology of coronavirus disease 2019: a protocol for the Berlin prospective COVID-19 patient cohort (Pa-COVID-19).
Kurth F; Roennefarth M; Thibeault C; Corman VM; Müller-Redetzky H; Mittermaier M; Ruwwe-Glösenkamp C; Heim KM; Krannich A; Zvorc S; Schmidt S; Kretzler L; Dang-Heine C; Rose M; Hummel M; Hocke A; Hübner RH; Opitz B; Mall MA; Röhmel J; Landmesser U; Pieske B; Knauss S; Endres M; Spranger J; Mockenhaupt FP; Tacke F; Treskatsch S; Angermair S; Siegmund B; Spies C; Weber-Carstens S; Eckardt KU; Schürmann D; Uhrig A; Stegemann MS; Zoller T; Drosten C; Suttorp N; Witzenrath M; Hippenstiel S; von Kalle C; Sander LE
Infection; 2020 Aug; 48(4):619-626. PubMed ID: 32535877
[TBL] [Abstract][Full Text] [Related]
3. Long-term health sequelae and quality of life at least 6 months after infection with SARS-CoV-2: design and rationale of the COVIDOM-study as part of the NAPKON population-based cohort platform (POP).
Horn A; Krist L; Lieb W; Montellano FA; Kohls M; Haas K; Gelbrich G; Bolay-Gehrig SJ; Morbach C; Reese JP; Störk S; Fricke J; Zoller T; Schmidt S; Triller P; Kretzler L; Rönnefarth M; Von Kalle C; Willich SN; Kurth F; Steinbeis F; Witzenrath M; Bahmer T; Hermes A; Krawczak M; Reinke L; Maetzler C; Franzenburg J; Enderle J; Flinspach A; Vehreschild J; Schons M; Illig T; Anton G; Ungethüm K; Finkenberg BC; Gehrig MT; Savaskan N; Heuschmann PU; Keil T; Schreiber S
Infection; 2021 Dec; 49(6):1277-1287. PubMed ID: 34642875
[TBL] [Abstract][Full Text] [Related]
4. The German National Pandemic Cohort Network (NAPKON): rationale, study design and baseline characteristics.
Schons M; Pilgram L; Reese JP; Stecher M; Anton G; Appel KS; Bahmer T; Bartschke A; Bellinghausen C; Bernemann I; Brechtel M; Brinkmann F; Brünn C; Dhillon C; Fiessler C; Geisler R; Hamelmann E; Hansch S; Hanses F; Hanß S; Herold S; Heyder R; Hofmann AL; Hopff SM; Horn A; Jakob C; Jiru-Hillmann S; Keil T; Khodamoradi Y; Kohls M; Kraus M; Krefting D; Kunze S; Kurth F; Lieb W; Lippert LJ; Lorbeer R; Lorenz-Depiereux B; Maetzler C; Miljukov O; Nauck M; Pape D; Püntmann V; Reinke L; Römmele C; Rudolph S; Sass J; Schäfer C; Schaller J; Schattschneider M; Scheer C; Scherer M; Schmidt S; Schmidt J; Seibel K; Stahl D; Steinbeis F; Störk S; Tauchert M; Tebbe JJ; Thibeault C; Toepfner N; Ungethüm K; Vadasz I; Valentin H; Wiedmann S; Zoller T; Nagel E; Krawczak M; von Kalle C; Illig T; Schreiber S; Witzenrath M; Heuschmann P; Vehreschild JJ;
Eur J Epidemiol; 2022 Aug; 37(8):849-870. PubMed ID: 35904671
[TBL] [Abstract][Full Text] [Related]
5. Ethical and coordinative challenges in setting up a national cohort study during the COVID-19 pandemic in Germany.
Tilch K; Hopff SM; Appel K; Kraus M; Lorenz-Depiereux B; Pilgram L; Anton G; Berger S; Geisler R; Haas K; Illig T; Krefting D; Lorbeer R; Mitrov L; Muenchhoff M; Nauck M; Pley C; Reese JP; Rieg S; Scherer M; Stecher M; Stellbrink C; Valentin H; Winter C; Witzenrath M; Vehreschild JJ
BMC Med Ethics; 2023 Oct; 24(1):84. PubMed ID: 37848886
[TBL] [Abstract][Full Text] [Related]
6. Travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E
Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
8. International travel-related control measures to contain the COVID-19 pandemic: a rapid review.
Burns J; Movsisyan A; Stratil JM; Biallas RL; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Klinger C; Kratzer S; Litwin T; Norris S; Pfadenhauer LM; von Philipsborn P; Sell K; Stadelmaier J; Verboom B; Voss S; Wabnitz K; Rehfuess E
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013717. PubMed ID: 33763851
[TBL] [Abstract][Full Text] [Related]
9. Chronic neuropsychiatric sequelae of SARS-CoV-2: Protocol and methods from the Alzheimer's Association Global Consortium.
de Erausquin GA; Snyder H; Brugha TS; Seshadri S; Carrillo M; Sagar R; Huang Y; Newton C; Tartaglia C; Teunissen C; Håkanson K; Akinyemi R; Prasad K; D'Avossa G; Gonzalez-Aleman G; Hosseini A; Vavougios GD; Sachdev P; Bankart J; Mors NPO; Lipton R; Katz M; Fox PT; Katshu MZ; Iyengar MS; Weinstein G; Sohrabi HR; Jenkins R; Stein DJ; Hugon J; Mavreas V; Blangero J; Cruchaga C; Krishna M; Wadoo O; Becerra R; Zwir I; Longstreth WT; Kroenenberg G; Edison P; Mukaetova-Ladinska E; Staufenberg E; Figueredo-Aguiar M; Yécora A; Vaca F; Zamponi HP; Re VL; Majid A; Sundarakumar J; Gonzalez HM; Geerlings MI; Skoog I; Salmoiraghi A; Boneschi FM; Patel VN; Santos JM; Arroyo GR; Moreno AC; Felix P; Gallo C; Arai H; Yamada M; Iwatsubo T; Sharma M; Chakraborty N; Ferreccio C; Akena D; Brayne C; Maestre G; Blangero SW; Brusco LI; Siddarth P; Hughes TM; Zuñiga AR; Kambeitz J; Laza AR; Allen N; Panos S; Merrill D; Ibáñez A; Tsuang D; Valishvili N; Shrestha S; Wang S; Padma V; Anstey KJ; Ravindrdanath V; Blennow K; Mullins P; Łojek E; Pria A; Mosley TH; Gowland P; Girard TD; Bowtell R; Vahidy FS
Alzheimers Dement (N Y); 2022; 8(1):e12348. PubMed ID: 36185993
[TBL] [Abstract][Full Text] [Related]
10. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
11. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.
Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665
[TBL] [Abstract][Full Text] [Related]
12. National strategy for palliative care of severely ill and dying people and their relatives in pandemics (PallPan) in Germany - study protocol of a mixed-methods project.
Bausewein C; Hodiamont F; Berges N; Ullrich A; Gerlach C; Oechsle K; Pauli B; Weber J; Stiel S; Schneider N; Krumm N; Rolke R; Gebel C; Jansky M; Nauck F; Wedding U; van Oorschot B; Roch C; Werner L; Fischer M; Schallenburger M; Reuters MC; Schwartz J; Neukirchen M; Gülay A; Maus K; Jaspers B; Radbruch L; Heckel M; Klinger I; Ostgathe C; Kriesen U; Junghanß C; Lehmann E; Gesell D; Gauder S; Boehlke C; Becker G; Pralong A; Strupp J; Leisse C; Schloesser K; Voltz R; Jung N; Simon ST;
BMC Palliat Care; 2022 Jan; 21(1):10. PubMed ID: 35027041
[TBL] [Abstract][Full Text] [Related]
13. Measures implemented in the school setting to contain the COVID-19 pandemic.
Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252
[TBL] [Abstract][Full Text] [Related]
14. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
[TBL] [Abstract][Full Text] [Related]
15. Comparing SARS-CoV-2 variants among children and adolescents in Germany: relative risk of COVID-19-related hospitalization, ICU admission and mortality.
Jank M; Oechsle AL; Armann J; Behrends U; Berner R; Chao CM; Diffloth N; Doenhardt M; Hansen G; Hufnagel M; Lander F; Liese JG; Muntau AC; Niehues T; von Both U; Verjans E; Weil K; von Kries R; Schroten H
Infection; 2023 Oct; 51(5):1357-1367. PubMed ID: 36787015
[TBL] [Abstract][Full Text] [Related]
16. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
[TBL] [Abstract][Full Text] [Related]
17. Severity, predictors and clinical correlates of Post-COVID syndrome (PCS) in Germany: A prospective, multi-centre, population-based cohort study.
Bahmer T; Borzikowsky C; Lieb W; Horn A; Krist L; Fricke J; Scheibenbogen C; Rabe KF; Maetzler W; Maetzler C; Laudien M; Frank D; Ballhausen S; Hermes A; Miljukov O; Haeusler KG; Mokhtari NEE; Witzenrath M; Vehreschild JJ; Krefting D; Pape D; Montellano FA; Kohls M; Morbach C; Störk S; Reese JP; Keil T; Heuschmann P; Krawczak M; Schreiber S;
EClinicalMedicine; 2022 Sep; 51():101549. PubMed ID: 35875815
[TBL] [Abstract][Full Text] [Related]
18. Protocol for SARS-CoV-2 post-vaccine surveillance study in Australian adults and children with cancer: an observational study of safety and serological and immunological response to SARS-CoV-2 vaccination (SerOzNET).
Body A; Ahern E; Lal L; Gillett K; Abdulla H; Opat S; O'Brien T; Downie P; Turville S; Munier CML; Smith C; MacIntyre CR; Segelov E
BMC Infect Dis; 2022 Jan; 22(1):70. PubMed ID: 35057745
[TBL] [Abstract][Full Text] [Related]
19. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
Trials; 2021 May; 22(1):343. PubMed ID: 34001215
[TBL] [Abstract][Full Text] [Related]
20. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
